These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3024488)

  • 1. The effect of estrogen-progestin treatment on opioid control of gonadotropin and prolactin secretion in postmenopausal women.
    Dawood MY; Khan-Dawood FS; Ramos J
    Am J Obstet Gynecol; 1986 Dec; 155(6):1246-51. PubMed ID: 3024488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
    Gallagher JC; Kable WT; Goldgar D
    Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestins increase endogenous opioid peptide activity in postmenopausal women.
    Casper RF; Alapin-Rubillovitz S
    J Clin Endocrinol Metab; 1985 Jan; 60(1):34-6. PubMed ID: 3155455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroids modulate prolactin response to naloxone in postmenopausal women.
    Melis GB; Gambacciani M; Paoletti AM; Mais V; Cagnacci A; Petacchi FD; Fioretti P
    Neuroendocrinology; 1985 Aug; 41(2):138-41. PubMed ID: 2995857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives.
    Snowden EU; Khan-Dawood FS; Dawood MY
    Am J Obstet Gynecol; 1986 Feb; 154(2):440-4. PubMed ID: 3080893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
    Shoupe D; Montz FJ; Lobo RA
    J Clin Endocrinol Metab; 1985 Jan; 60(1):178-83. PubMed ID: 2981084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using naloxone.
    Melis GB; Paoletti AM; Gambacciani M; Mais V; Fioretti P
    Neuroendocrinology; 1984 Jul; 39(1):60-3. PubMed ID: 6087184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women.
    Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P
    J Clin Endocrinol Metab; 1990 Feb; 70(2):365-70. PubMed ID: 2105330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
    Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
    Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
    Bewtra C; Kable WT; Gallagher JC
    J Reprod Med; 1988 Feb; 33(2):205-8. PubMed ID: 2832598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease.
    Cagnacci A; Melis GB; Soldani R; Bonuccelli U; Piccini P; Napolitano A; Muratorio A; Fioretti P
    Neuroendocrinology; 1991 Jun; 53(6):549-55. PubMed ID: 1678880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of sexual function in a castrated man treated with ovarian steroids.
    Davidson JM; Camargo C; Smith ER; Kwan M
    Arch Sex Behav; 1983 Jun; 12(3):263-74. PubMed ID: 6309119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating actions of estradiol on gonadotropin-releasing hormone-stimulated prolactin secretion in postmenopausal individuals.
    Christiansen E; Veldhuis JD; Rogol AD; Stumpf P; Evans WS
    Am J Obstet Gynecol; 1987 Aug; 157(2):320-5. PubMed ID: 3113249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women.
    Pickett CK; Regensteiner JG; Woodard WD; Hagerman DD; Weil JV; Moore LG
    J Appl Physiol (1985); 1989 Apr; 66(4):1656-61. PubMed ID: 2543656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
    Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
    Snowden EU; Khan-Dawood FS; Dawood MY
    J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.